Pricing Log in Create free account

Adlai Nortye Ltd. Sponsored ADR (ANL) vs Sana Biotechnology, Inc. (SANA)

Adlai Nortye Ltd. Sponsored ADR and Sana Biotechnology, Inc. are both Biotechnology companies. Adlai Nortye Ltd. Sponsored ADR and Sana Biotechnology, Inc. are of similar size ($740.9M and $710.1M). Across the 7 metrics below, Adlai Nortye Ltd. Sponsored ADR leads on 6 and Sana Biotechnology, Inc. on 1.

Valuation

Metric ANL SANA Biotechnology median
P/E — n/m 8.50
P/S — n/m 9.71
P/B n/m 4.34 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield — (33.48%) (33.15%)
Free cash flow yield 0.00% (19.96%) (25.50%)

Profitability

Metric ANL SANA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (152.87%) (56.36%)
Return on assets 0.00% (53.41%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANL SANA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 31.48% 17.24% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ANL SANA Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 9.55 1.38 4.72
Net debt to EBITDA (0.05) 0.60 0.96

Dividend

Metric ANL SANA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANL SANA Biotechnology median
Market cap 710.05m 740.92m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack